A Missouri state court has granted final approval to a $7.25 billion nationwide class-action settlement, marking a significant turning point in the long-running legal battle over the herbicide Roundup. The ruling effectively resolves tens of thousands of lawsuits brought by individuals who alleged that the product, manufactured by Bayer, caused them to develop non-Hodgkin lymphoma.
The decision provides a structured path for compensation for victims who have sought legal recourse for over a decade.
Resolving a Decade of Litigation
The legal challenges have dogged Bayer for a decade. The company has faced a massive liability, as Roundup—the world’s most widely used herbicide—became the subject of tens of thousands of lawsuits. Plaintiffs consistently argued that the company failed to provide adequate warnings regarding the potential cancer risks associated with the product.
Bayer maintained that its labeling complied with federal standards. The conflict reached the U.S. Supreme Court this summer, which ruled in favor of Bayer. The Court’s decision barred plaintiffs from suing the company in state courts over the lack of warning labels, a ruling that significantly bolstered Bayer’s legal position.
Compensation and Financial Impact
Bayer has spent years litigating in courtrooms across the country and has settled tens of thousands of cases individually or in groups before this latest class-action settlement. The company previously stated that its litigation costs related to Roundup were at least $14 billion.
A Path Toward Stability
Bayer described the court’s final approval as a "decisive milestone" in the company’s strategy to mitigate the risks of the lawsuits. With Friday’s final approval of the settlement, Bayer will be able to put most Roundup lawsuits behind it.
By finalizing this settlement, Bayer aims to move past the legal uncertainty that has impacted its business operations for years. This ruling provides a definitive framework to address the claims of those affected by the herbicide.

